EFM
E Fund Management’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.4K | Buy |
10,987
+489
| +5% | +$3.98K | ﹤0.01% | 378 |
|
|
2025
Q1 | $82.4K | Buy |
+10,498
| New | +$82.4K | ﹤0.01% | 388 |
|
|
2024
Q2 | – | Sell |
-16,052
| Closed | -$303K | – | 365 |
|
|
2024
Q1 | $303K | Buy |
16,052
+2,551
| +19% | +$48.2K | 0.02% | 274 |
|
|
2023
Q4 | $258K | Sell |
13,501
-1,537
| -10% | -$29.4K | 0.02% | 252 |
|
|
2023
Q3 | $270K | Sell |
15,038
-1,098
| -7% | -$19.7K | 0.02% | 220 |
|
|
2023
Q2 | $328K | Sell |
16,136
-7,199
| -31% | -$146K | 0.03% | 207 |
|
|
2023
Q1 | $426K | Buy |
23,335
+13,121
| +128% | +$240K | 0.03% | 146 |
|
|
2022
Q4 | $211K | Sell |
10,214
-5,506
| -35% | -$114K | 0.02% | 295 |
|
|
2022
Q3 | $411K | Sell |
15,720
-2,055
| -12% | -$53.7K | 0.04% | 176 |
|
|
2022
Q2 | $450K | Buy |
17,775
+9,670
| +119% | +$245K | 0.04% | 164 |
|
|
2022
Q1 | $256K | Buy |
+8,105
| New | +$256K | 0.01% | 254 |
|